Nesa Medtech appoints Padma Shri Awardee Dr. Manjula Anagani as its Scientific Advisory Chair

New Delhi (India), January 5: Nesa Medtech, a pioneering medical device startup, announces the appointment of Padma Shri Awardee Dr. Manjula Anagani to its esteemed Scientific Advisory Board. Dr. Anagani, a renowned surgeon in the field of gynecology and women’s health, brings a wealth of expertise and experience to Nesa Medtech‘s innovative endeavors. Dr. Anagani’s accolades and contributions […]

PNN
PNN Verified Media or Organization • 16 Apr, 2026 Author
Jan 5, 2024 • 12:32 PM
P
Press Release
NEWS CARD
Logo
Nesa Medtech appoints Padma Shri Awardee Dr. Manjula Anagani as its Scientific Advisory Chair
“Nesa Medtech appoints Padma Shri Awardee Dr. Manjula Anagani as its Scientific Advisory Chair”
Favicon
Read more on en.sangritimes.com
5 Jan 2024
https://en.sangritimes.com/nesa-medtech-appoints-padma-shri-awardee-dr-manjula-anagani-as-its-scientific-advisory-chair
Copied
Nesa Medtech appoints Padma Shri Awardee Dr. Manjula Anagani as its Scientific Advisory Chair

New Delhi (India), January 5: Nesa Medtech, a pioneering medical device startup, announces the appointment of Padma Shri Awardee Dr. Manjula Anagani to its esteemed Scientific Advisory Board. Dr. Anagani, a renowned surgeon in the field of gynecology and women’s health, brings a wealth of expertise and experience to Nesa Medtech‘s innovative endeavors. Dr. Anagani’s accolades and contributions to medical science are multifaceted. Her pioneering work in laparoscopic techniques and revolutionary advancements in addressing primary amenorrhea, stem cell procedures for endometrial regeneration, and neovagina creation stand as a proof of her groundbreaking contributions in the field. Honored with the prestigious Padma Shri award by the Government of India in 2015, she is one of the most respected names in the Indian Medical Fraternity. 

Nesa Medtech, under the leadership of CEO and Founder Sreekar Kothamachu, has been at the forefront of innovation in the medical field. Their patented microinvasive technique for treating symptomatic uterine fibroids, developed after years of extensive research and development. Nesa’s unique technology enable the shrinking of fibroids under real-time ultrasound guidance, promising quicker recovery, no cut/suture, and the preservation of the uterus.

history This is an archived post. The information provided may be outdated.

PNN Verified Media or Organization • 16 Apr, 2026 Author

Agency

home Home amp_stories Web Stories local_fire_department Trending play_circle Videos mark_email_unread Newsletter